Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
650 |
|
| Actual shortage: | 12 (2%) | |
| Anticipated shortage: | 7 (1%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (84%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
82 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VARDENAFIL | 20MG | TABLET | Resolved | 2023-03-20 | 2023-05-23 | 187546 |
| MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2023-01-17 | 2023-05-25 | 181289 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-01-23 | 2023-07-14 | 182205 |
| MYLAN-LAMOTRIGINE | 25MG | TABLET | Resolved | 2023-06-21 | 2023-07-14 | 196047 |
| VITAMIN C | 500MG | SOLUTION | Resolved | 2023-04-20 | 2023-07-18 | 189880 |
| MYLAN-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-05-01 | 2023-08-01 | 191317 |
| MYLAN-CILAZAPRIL | 5.0MG | TABLET | Resolved | 2023-05-31 | 2023-08-01 | 193448 |
| MYLAN-BACLOFEN | 20MG | TABLET | Resolved | 2023-04-20 | 2023-08-16 | 189891 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-06-21 | 2023-08-16 | 196061 |
| MYLAN-ATOVAQUONE/PROGUANIL | 100MG 250MG | TABLET | Resolved | 2023-04-12 | 2023-08-21 | 189338 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-05-31 | 2023-08-29 | 193442 |
| MYLAN-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-27 | 2023-08-29 | 196698 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-05-01 | 2023-08-29 | 191357 |
| MYLAN-VARDENAFIL | 5MG | TABLET | Resolved | 2023-06-27 | 2023-09-06 | 196692 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2022-11-17 | 2023-09-06 | 175112 |
| MYLAN-FLUCONAZOLE | 100MG | TABLET | Resolved | 2023-09-11 | 2023-09-26 | 204098 |
| MYLAN-TADALAFIL | 20MG | TABLET | Avoided shortage | 2023-09-20 | 2023-09-26 | 204802 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Avoided shortage | 2023-08-01 | 2023-10-03 | 200648 |
| MYLAN-BACLOFEN | 10MG | TABLET | Resolved | 2023-04-20 | 2023-10-03 | 189894 |
| MYLAN-MIRTAZAPINE | 45MG | TABLET | Resolved | 2023-03-07 | 2023-10-03 | 186407 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |